SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 278 filers reported holding SAGE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $228,286 | -40.2% | 4,855 | -46.7% | 0.00% | -100.0% |
Q1 2023 | $381,882 | +19.0% | 9,101 | +10.9% | 0.00% | 0.0% |
Q3 2022 | $321,000 | +39.0% | 8,207 | +14.4% | 0.00% | – |
Q2 2022 | $231,000 | -92.6% | 7,172 | -86.9% | 0.00% | -100.0% |
Q2 2021 | $3,128,000 | -20.5% | 54,860 | +5.8% | 0.01% | -30.0% |
Q1 2021 | $3,937,000 | -9.0% | 51,847 | +3.2% | 0.01% | -9.1% |
Q4 2020 | $4,327,000 | +93.5% | 50,224 | +37.1% | 0.01% | +83.3% |
Q3 2020 | $2,236,000 | +88.9% | 36,639 | +28.6% | 0.01% | +50.0% |
Q2 2020 | $1,184,000 | +95.4% | 28,482 | +29.5% | 0.00% | +100.0% |
Q1 2020 | $606,000 | -74.2% | 22,000 | -32.8% | 0.00% | -71.4% |
Q4 2019 | $2,345,000 | -74.2% | 32,739 | -49.4% | 0.01% | -69.6% |
Q3 2019 | $9,073,000 | -21.0% | 64,708 | +3.2% | 0.02% | -39.5% |
Q2 2019 | $11,484,000 | +29.0% | 62,679 | +11.8% | 0.04% | +26.7% |
Q1 2019 | $8,900,000 | +1288.5% | 56,039 | +1067.0% | 0.03% | +1400.0% |
Q4 2018 | $641,000 | +3.1% | 4,802 | +8.2% | 0.00% | 0.0% |
Q3 2018 | $622,000 | -64.7% | 4,437 | -60.6% | 0.00% | -66.7% |
Q2 2018 | $1,764,000 | +176300.0% | 11,274 | +225380.0% | 0.01% | – |
Q1 2018 | $1,000 | -99.6% | 5 | -99.9% | 0.00% | -100.0% |
Q3 2016 | $263,000 | +3657.1% | 5,702 | +2336.8% | 0.00% | – |
Q2 2016 | $7,000 | 0.0% | 234 | +7.3% | 0.00% | – |
Q1 2016 | $7,000 | -46.2% | 218 | -3.5% | 0.00% | – |
Q4 2015 | $13,000 | -94.8% | 226 | -96.2% | 0.00% | -100.0% |
Q3 2015 | $250,000 | -31.7% | 5,916 | +18.0% | 0.00% | -33.3% |
Q2 2015 | $366,000 | +49.4% | 5,015 | +2.6% | 0.00% | +50.0% |
Q1 2015 | $245,000 | +12150.0% | 4,890 | +7787.1% | 0.00% | – |
Q4 2014 | $2,000 | – | 62 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |